Almorexant HCl
| CAS No. | 913358-93-7 | Cat. No. | BCP08993 |
| Name | Almorexant HCl | ||
| Synonyms | Almorexant hydrochloride;ACT-078573 hydrochloride; ACT 078573 hydrochloride; ACT078573 hydrochloride; | ||
| Formula | C29H31F3N2O3.HCl | M. Wt | 549.03 |
| Description | Almorexant HCl, also known as ACT-078573, is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011. Almorexant is a competitive, dual OX1 and OX2 receptor antagonist and selectively inhibits the functional consequences of OX1 and OX2 receptor activation, such as intracellular Ca2+ mobilization. | ||
| Related Products | 871224-64-5（Almorexant） | ||
| Pathways | GPCR/G Protein | ||
| Targets | OX Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.